Meta-analysisindependent cross-checkabstract checked★ key study I-ORG-105 in-depth review

How often silent gallstones start causing problems

Asymptomatic gallstones: Cumulative incidence proportion, incidence rate, and risk factors for symptoms development: Systematic review and meta-analysis.

Overview

Alzoubi M et al.. PLoS One 2026 · PMID 41886405 · DOI 10.1371/journal.pone.0345462

About 10% of people with silent gallstones develop symptoms within 5 years and about 19% within 10 years.

Does the study support the specific claim? Partly · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Estimate how often incidental gallstones become symptomatic

How was the study done?

Meta-analysis of 8 cohort studies

How many people, animals or samples were studied?

25,924 adults

What was actually found?

Symptoms in 10% at 5 y, 19% at 10 y, 26% at 15 y

How large was the observed effect?

About 2% per year

What do the results mean in everyday life?

Most silent stones can be left alone, but they can cause symptoms later

What are the study's limitations?

Observational, heterogeneous studies

What does it say about Elawady's specific claim?

Partly supports (silent stones usually harmless), partly refutes (they can cause symptoms)

Do the results apply to Germany and Europe?

Directly applicable

What can explicitly not be concluded from this study?

Does not test diet

Scientific in-depth review

1. Full reference

Authors
Alzoubi M et al.
Journal
PLoS One
Year
2026
Identifier
PMID 41886405 DOI 10.1371/journal.pone.0345462
Verification
verified – PubMed efetch 2026-10-26; Crossref works API 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Not stated in abstract.

2. Research question

Cumulative incidence, incidence rate and risk factors of progression of incidentally found asymptomatic gallstones to symptomatic disease and complications.

3. Study design and population

Study design
Meta-analysis – Systematic review and meta-analysis of cohort studies (PROSPERO CRD42024526889)
Population

Adults with incidentally diagnosed gallstones

Country

Multinational (8 cohorts)

Period

Search to July 2025

Sample size

8 cohort studies (9 reports), 25,924 participants

Inclusion and exclusion criteria

Incidental gallstones; excluded known gallstone disease, bariatric surgery, cholecystectomy, pregnancy, oestrogen therapy, children

4. Methods and endpoints

Exposure / intervention

Asymptomatic gallstones (natural history)

Comparator

Single-arm proportions; risk factors compared with RR

Endpoints

Progression to symptomatic gallstone disease and complications

Statistical methods

Random-effects proportions; RR; I2

5. Actual results

Results

Cumulative incidence of symptomatic progression 0.10 (95% CI 0.10-0.11) at 5 years, 0.19 (0.14-0.25) at 10 years, 0.26 (0.12-0.40) at 15 years. Risk factors: alcohol RR 1.32 (1.27-1.38), hyperlipidaemia RR 1.19 (1.07-1.32); chronic liver disease RR 0.76 (0.67-0.87) and male sex RR 0.54 (0.33-0.87) protective.

Absolute risks

About 10% symptomatic at 5 years, 19% at 10 years, 26% at 15 years (about 2% per year).

Authors' conclusion

The review identifies factors for symptomatic progression of asymptomatic gallstones and may help identify high-risk patients who could benefit from prophylactic cholecystectomy.

6. Strengths

  • Registered protocol
  • Large pooled sample
  • Direct natural-history question

7. Weaknesses

  • Only 8 observational cohorts
  • Heterogeneous definitions
  • Wide CI at 15 years

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Registered and multi-database search; observational primary studies with heterogeneous follow-up.

9. Assessment of the statistical interpretation

Cumulative proportions translate to a roughly constant 2% annual risk (stats/C-ORG-07_gallstones.py).

10. Relevance to the specific claim

Quantifies how often 'silent' gallstones become symptomatic.

11. Independent contrary findings

None of note; consistent with Morris-Stiff 2023 (2% per year).

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Confirms that most incidental gallstones stay silent (supports part of the claim) but a substantial minority becomes symptomatic over 10-15 years (refutes 'no symptoms and no harm').

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Complication-specific rates (pancreatitis, cholecystitis).

15. Linked fact checks